We understand that some people may be concerned about getting vaccinated once a COVID-19 vaccine is available.
3 January 202111 July 2021
WHO recommendation COVID-19 mRNA vaccine (nucleoside modified) – COMIRNATY
Comirnaty, COVID-19 mRNA vaccine (nucleoside modified) is a vaccine for preventing coronavirus disease 2019 (COVID-19) in individuals aged 16 years and older
2 January 202114 November 2022
A Close-up of COVID-19 in Lung Cells
This image offers a striking example of exactly what happens to cells in the human airway when this coronavirus infects them.
21 December 202011 July 2021
European Medicines Agency recommends first COVID-19 vaccine for authorisation in the EU
European Medicines Agency (EMA) has recommended granting a conditional marketing authorisation for the vaccine Comirnaty - developed by BioNTech/Pfizer
11 December 202011 July 2021
FDA Takes Key Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for First COVID-19 Vaccine
The FDA’s authorization for emergency use of the first COVID-19 vaccine
11 December 202011 July 2021
Health Canada decision issued: Pfizer-BioNTech COVID-19 Vaccine was authorized for use in relation to the COVID-19 pandemic
Health Canada analysis of known and potential benefits and known and potential risks
11 December 202022 February 2021
Understanding mRNA COVID-19 Vaccines
mRNA vaccines are a new type of vaccine to protect against infectious diseases
11 December 202022 February 2021
Understanding How COVID-19 Vaccines Work
The Immune System—The Body’s Defense Against Infection